Clinical trials
Myocardial Infarction trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 6 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Terminated | 6 |
| Unknown status | 5 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Novartis Pharmaceuticals | 4 |
| Abant Izzet Baysal University | 2 |
| Cardiovascular Academy Society, Turkey | 2 |
| Dokuz Eylul University | 2 |
| Istanbul University - Cerrahpasa | 2 |
| Janssen Research & Development, LLC | 2 |
| Pfizer | 2 |
| Sanofi | 2 |
| AYNUR CİN | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Infarction | 50 |
| Stroke | 12 |
| Acute Coronary Syndrome | 11 |
| Cardiovascular Diseases | 8 |
| Coronary Artery Disease | 7 |
| Diabetes Mellitus | 5 |
| Angina, Unstable | 4 |
| Myocardial Ischemia | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Hyperlipidemias | 3 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.